Disclosures for "Clinical Features, Risk of Relapse, and Outcome in Anti-GABAA Receptor Encephalitis"
-
Dr. Papi has nothing to disclose.
-
Dr. Milano has nothing to disclose.
-
The institution of Dr. Iizuka has received research support from EUROIMMUN Japan Co., Ltd.
-
Dr. Simabukuro has nothing to disclose.
-
Miss Marmolejo Alcaide has nothing to disclose.
-
Mrs. Aguilar has nothing to disclose.
-
Dr. Guasp has nothing to disclose.
-
Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Therapeutics. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Iorio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen.
-
Dr. Fukami has nothing to disclose.
-
Prof. Santos has nothing to disclose.
-
Dr. Miwa has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for kyowa kirin co. ltd. Dr. Miwa has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai Co., Ltd..
-
Dr. ARAGA has nothing to disclose.
-
Dr. Uchida has nothing to disclose.
-
Dr. Kurihara has received personal compensation in the range of $0-$499 for serving as a Consultant for SANWA KAGAKU KENKYUSHO CO.,LTD.. Dr. Kurihara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai Co., Ltd.. Dr. Kurihara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Takeda Pharmaceutical Co., Ltd.. Dr. Kurihara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for AbbVie Inc.. Dr. Kurihara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Kyowa Kirin Co.,Ltd.. Dr. Kurihara has received research support from Japan Society for the Promotion of Science. Dr. Kurihara has received research support from Tokyo Metropolitan Institute for Geriatrics and Gerontology. Dr. Kurihara has received intellectual property interests from a discovery or technology relating to health care. Dr. Kurihara has a non-compensated relationship as a sub-investigator with Biogen Inc. that is relevant to AAN interests or activities. Dr. Kurihara has a non-compensated relationship as a sub-investigator with F. Hoffmann-La Roche, Ltd. that is relevant to AAN interests or activities. Dr. Kurihara has a non-compensated relationship as a sub-investigator with CHUGAI PHARMACEUTICAL CO.,LTD. that is relevant to AAN interests or activities. Dr. Kurihara has a non-compensated relationship as a sub-investigator with Janssen Pharmaceutical K.K. that is relevant to AAN interests or activities. Dr. Kurihara has a non-compensated relationship as a sub-investigator with Eli Lilly and Company that is relevant to AAN interests or activities. Dr. Kurihara has a non-compensated relationship as a sub-investigator with Sound Wave Innovation that is relevant to AAN interests or activities. Dr. Kurihara has a non-compensated relationship as a co-investigator with Sysmex Corporation that is relevant to AAN interests or activities. Dr. Kurihara has a non-compensated relationship as a sub-investigator with Eisai Co., Ltd. that is relevant to AAN interests or activities.
-
Dr. Okada has nothing to disclose.
-
Miss Garcia Ruiz has nothing to disclose.
-
Mr. Kaida has nothing to disclose.
-
Dr. Cunha has nothing to disclose.
-
Alberto Vogrig has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Eisai. Alberto Vogrig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini. The institution of Alberto Vogrig has received research support from Ministero della Salute, Bando Ricerca Finalizzata.
-
Mr. LAMBLIN has nothing to disclose.
-
The institution of Dr. Dutra has received research support from Hospital Israelita Albert Einstein.
-
Romana Hoeftberger has received personal compensation in the range of $500-$4,999 for serving as a speaker with Euroimmun and UCB Biopharma.
-
Juna De Vries has nothing to disclose.
-
The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received publishing royalties from a publication relating to health care.
-
The institution of Dr. Sabater has received research support from Instituto de Salud Carlos III.
-
Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez-Hernandez has received research support from Instituto de Salud Carlos III. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with Sanofi. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings and speaker honoraria with UCB. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a speaker honoraria with Alexion. Dr. Martinez-Hernandez has received personal compensation in the range of $0-$499 for serving as a speaker honoraria with Terumo. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with Janssen. Dr. Martinez-Hernandez has received personal compensation in the range of $500-$4,999 for serving as a support for attending meetings with CSL Behring.
-
Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP.
-
Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
-
The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation.